A Study of LY3867070 in Healthy Participants

Part of paid clinical trials in Anaheim, California.

Sponsor
Eli Lilly and Company
Study ID
NCT07021547
Phase
PHASE1
Status
Recruiting
Apply to this trial

Conditions

  • Healthy

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Accepted

Interventions

  • LY3867070 — DRUG
    Administered orally
  • Placebo — DRUG
    Administered orally

Study Details

The purpose of this study is to evaluate how well LY3867070 is tolerated and what side effects may occur in healthy participants. The study drug will be administered orally. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body.

Key Dates

Start date
May 27, 2025
Status verified
Jun 2026
Primary completion
Aug 31, 2026
Completion
Aug 31, 2026

Study Design

Enrollment
196 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: LY3867070 (Part A)
    Single-Ascending Dose of LY3867070 administered orally
  • Experimental: LY3867070 (Part B)
    Multiple-Ascending Doses of LY3867070 administered orally
  • Experimental: LY3867070 (Part C)
    Multiple Doses of LY3867070 administered orally
  • Placebo Comparator: Placebo (Parts A-C)
    Placebo administered orally
  • Experimental: LY3867070 (Part D)
    Drug-Drug Interaction (DDI) administered orally

Primary Outcome Measure

Number of Participants with One or More Treatment Emergent Adverse Events (TEAEs) Considered by the Investigator to be Related to Study Drug Administration [ Time Frame: Baseline up to Approximately Week 7 ]

Central Contacts

  • Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
    1-317-615-4559
    [email protected]
  • Physicians interested in becoming principal investigators please contact
    [email protected]

Locations (2)

FacilityCityStateZIPSite coordinators
Anaheim Clinical Trials, LLCAnaheimCalifornia92801
714-774-7777, ext. 1012
Amina Haggag (PRINCIPAL_INVESTIGATOR)
Fortrea Clinical Research UnitDallasTexas75247
866-429-3700
Gene Voskuhl (PRINCIPAL_INVESTIGATOR)

Find similar trials in Anaheim, CA

By research site
Anaheim Clinical Trials, LLC· Anaheim, CAFortrea Clinical Research Unit· Dallas, TX

Related Studies